In this report, our team offers a comprehensive analysis of Aurora Kinase A market, SWOT analysis of the most prominent players in this landscape. Along with an industrial chain, market statistics in terms of revenue, sales, price, capacity, regional market analysis, segment-wise data, and market forecast information are offered in the full study, etc.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.
...
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Aurora Kinase A Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 AMG-900
1.3.2 Danusertib
1.3.3 ENMD-2076
1.3.4 Ilorasertib
1.3.5 Others
1.4 Application Overview
1.4.1 Ovarian Cancer
1.4.2 Anaplastic Large Cell Lymphoma
1.4.3 Brain Tumor
1.4.4 Others
1.5 Industrial Chain
1.5.1 Aurora Kinase A Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 AMG-900
2.1.2 Danusertib
2.1.3 ENMD-2076
2.1.4 Ilorasertib
2.1.5 Others
2.2 The Overall Market Performance(Value)
2.2.1 AMG-900
2.2.2 Danusertib
2.2.3 ENMD-2076
2.2.4 Ilorasertib
2.2.5 Others
3 Global Aurora Kinase A Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Ovarian Cancer
3.3 Anaplastic Large Cell Lymphoma
3.4 Brain Tumor
3.5 Others
4 Competitive Analysis
4.1 AbbVie Inc.
4.1.1 AbbVie Inc. Profiles
4.1.2 AbbVie Inc. Product Information
4.1.3 AbbVie Inc. Aurora Kinase A Business Performance
4.1.4 SWOT Analysis
4.2 Amgen Inc.
4.2.1 Amgen Inc. Profiles
4.2.2 Amgen Inc. Product Information
4.2.3 Amgen Inc. Aurora Kinase A Business Performance
4.2.4 SWOT Analysis
4.3 Astex Pharmaceuticals, Inc.
4.3.1 Astex Pharmaceuticals, Inc. Profiles
4.3.2 Astex Pharmaceuticals, Inc. Product Information
4.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Business Performance
4.3.4 SWOT Analysis
4.4 CASI Pharmaceuticals Inc.
4.4.1 CASI Pharmaceuticals Inc. Profiles
4.4.2 CASI Pharmaceuticals Inc. Product Information
4.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Business Performance
4.4.4 SWOT Analysis
4.5 Merck & Co., Inc.
4.5.1 Merck & Co., Inc. Profiles
4.5.2 Merck & Co., Inc. Product Information
4.5.3 Merck & Co., Inc. Aurora Kinase A Business Performance
4.5.4 SWOT Analysis
4.6 Millennium Pharmaceuticals, Inc.
4.6.1 Millennium Pharmaceuticals, Inc. Profiles
4.6.2 Millennium Pharmaceuticals, Inc. Product Information
4.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Business Performance
4.6.4 SWOT Analysis
4.7 Sanofi
4.7.1 Sanofi Profiles
4.7.2 Sanofi Product Information
4.7.3 Sanofi Aurora Kinase A Business Performance
4.7.4 SWOT Analysis
4.8 Sareum Holdings Plc
4.8.1 Sareum Holdings Plc Profiles
4.8.2 Sareum Holdings Plc Product Information
4.8.3 Sareum Holdings Plc Aurora Kinase A Business Performance
4.8.4 SWOT Analysis
4.9 Sigma-Tau S.p.A.
4.9.1 Sigma-Tau S.p.A. Profiles
4.9.2 Sigma-Tau S.p.A. Product Information
4.9.3 Sigma-Tau S.p.A. Aurora Kinase A Business Performance
4.9.4 SWOT Analysis
4.10 Taiho Pharmaceutical Co., Ltd.
4.10.1 Taiho Pharmaceutical Co., Ltd. Profiles
4.10.2 Taiho Pharmaceutical Co., Ltd. Product Information
4.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Business Performance
4.10.4 SWOT Analysis
4.11 Vertex Pharmaceuticals Incorporated
4.12 Vichem Chemie Research Ltd.
5 Competitive Lanscape
5.1 Global Aurora Kinase A Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Aurora Kinase A Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America Aurora Kinase A Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America Aurora Kinase A Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America Aurora Kinase A Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global Aurora Kinase A Market Assessment by Regions
7.1 Global Aurora Kinase A Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global Aurora Kinase A Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global Aurora Kinase A Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global Aurora Kinase A Price (USD/Unit) by Regions (2014-2020)
7.5 Global Aurora Kinase A Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.2 China Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.3 USA Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.4 Europe Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.5 Japan Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.6 Korea Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.7 India Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia Aurora Kinase A Capacity and Growth Rate (2014-2020)
8.9 South America Aurora Kinase A Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global Aurora Kinase A Major Manufacturers
11 Global Aurora Kinase A Market Forecast by Regions
11.1 Global Aurora Kinase A Market Forecast (2021-2026)
11.1.1 Global Aurora Kinase A Capacity Forecast by Regions (2021-2026)
11.1.2 Global Aurora Kinase A Sales Forecast by Regions (2021-2026)
11.1.2 Global Aurora Kinase A Revenue Forecast by Regions (2021-2026)
11.2 China Aurora Kinase A Market Forecast (2021-2026)
11.3 USA Aurora Kinase A Market Forecast (2021-2026)
11.4 Europe Aurora Kinase A Market Forecast (2021-2026)
11.5 Japan Aurora Kinase A Market Forecast (2021-2026)
11.6 Korea Aurora Kinase A Market Forecast (2021-2026)
11.7 India Aurora Kinase A Market Forecast (2021-2026)
11.8 Southeast Asia Aurora Kinase A Market Forecast (2021-2026)
11.9 South America Aurora Kinase A Market Forecast (2021-2026)
12 Global Aurora Kinase A Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 AMG-900
12.3 Danusertib
12.4 ENMD-2076
12.5 Ilorasertib
12.6 Others
13 Global Aurora Kinase A Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Ovarian Cancer
13.3 Anaplastic Large Cell Lymphoma
13.4 Brain Tumor
13.5 Others
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global Aurora Kinase A Average Price Forecast (2021-2026)
14.2 Global Aurora Kinase A Gross Profit Forecast (2021-2026)
15 Conclusion
Overview of the Global Kinase Panel Screening and Profiling Market:
The report discusses everything a marketer requires before investing in the global Kinase Panel Screening and Profiling Market during the forecast ...
The global Non-Tyrosine Kinase Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market playe...
The global Creatine Kinase Test market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Tyrosine Protein Kinase BTK market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players ...
The global Creatine Kinase Test Kit market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Small Molecule Tyrosine Kinase Inhibitor market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help ma...
The global Tyrosine Kinase Inhibitor market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...
The global Bruton Tyrosine Kinase (BTK) Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mar...
Overview of the Global Cyclin Dependent Kinase (CDK) Inhibitors Market:
The report discusses everything a marketer requires before investing in the global Cyclin Dependent Kinase (CDK) Inhibitors Market during the f...
Overview of the Global Kinase Inhibitor In Autoimmune Diseases Market:
The report discusses everything a marketer requires before investing in the global Kinase Inhibitor In Autoimmune Diseases Market during the for...